BSEAGM/EGM4h ago · 22 Jul 2026, 07:19 pm
Notice of the Ninth Annual General Meeting for the Financial Year 2025-26 is attched.
Amwill Health Care Ltd · 544353
✦ AI SummaryResults
Amwill Health Care Ltd has announced its 9th Annual General Meeting (AGM) for the financial year 2025-26, to be held on August 14th, 2026. The meeting will consider the audited financial statements, declare the final dividend, and appoint a director. The company has also fixed August 8th, 2026 as the cut-off date for shareholders to be eligible to cast their votes electronically.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk2/10
Liquidity Impact8/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Amwill Health Care Ltd - 544353 - Notice Of The Ninth Annual General Meeting For The Financial Year 2025-26
Attachments (1)
📄pdf
Download →
76354384-2306-4ca9-94bf-cde63d21d67e.pdf
View document text
Date: July 22, 2026
The Bombay Stock Exchange
(BSE Limited)
Phiroze Jeejeebhoy Towers,
Dalal Street,
Mumbai- 400001
Scrip Name: AMWILL HEALTH CARE LIMITED.
Company Scrip Code.: 544353
Subject: Notice of 09th Annual General Meeting along with Annual Report of the Company for the
Financial Year 2025-26
Dear Sir / Madam,
This is to inform that the 09th Annual General Meeting (“AGM”) of the Company will be held on Friday,
August 14th, 2026 at 01.00 P.M. (IST) through Video Conferencing/ Other Audio-Visual Means (“OAVM”)
in accordance with the applicable circulars issued by the Ministry of Corporate Affairs and Securities and
Exchange Board of India. Pursuant to Regulation 34(1) of Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we are submitting herewith the Annual
Report of the Company along with the Notice of AGM for the financial year 2025-26, which is being sent
only through electronic mode to the Shareholders. The Annual Report containing the AGM Notice is also
uploaded on the Company’s website www.amwillhealthcare.com . We would further like to inform that the
Company has fixed Saturday, August 08th, 2026 as the cut-off date for ascertaining the names of the
shareholders holding shares either in physical form or in dematerialized form, who will be entitled to cast
their votes electronically in respect of the businesses to be transacted as per the Notice of the AGM and to
attend the AGM. The remote e-voting period starts from 09:00 A.M. (IST) on Tuesday, August 11, 2026 and will
end on 05:00 P.M. (IST) on Thursday, August 13, 2026.
Further, in accordance with Regulation 36 of SEBI Listing Regulations, a letter providing web-link for
accessing the Annual Report for FY 2025-26 and notice of 09th AGM will be sent to all those Members who
have not registered their email Ids via post.
This information will also be made available on the Company’s Website at: www.amwillhealthcare.com.
This is for your records and information.
Thanking You.
FOR AMWILL HEALTH CARE LIMITED
Anshu Anshuman
Company secretary and compliance Officer
ACS65515
Address: No. 90,4th Floor, 2nd Main, 7th Cross, Chamrajpet,
Bangalore, Karnataka, India, 560018
Place: Bangalore
Notice of 9th AGM
Amwill Health Care Limited
Corporate Identity Number: L36994KA2017PLC105721
Registered O ce: No. 90,4th Floor, 2nd Main, 7th Cross, Chamrajpet,
Bangalore, Karnataka, India, 560018
Website: www.amwillhealthcare.com E-mail ID: investors@amwillhealthcare.com
Telephone: +91 080 26605825
NOTICE
(Pursuant to Section 101 of the Companies Act, 2013)
NOTICE is hereby given that 09th (Ninth) Annual General Meeting of the Members of AMWILL HEALTH
CARE LIMITED (“The Company”) will be held on 14th August, 2026 at 01:00 P.M. (IST) through Video
Conferencing / Other Audio-Visual Means (“VC” “OAVM”), to transact the following business:
ORDINARY BUSINESS:
1. To receive, consider, and adopt the Audited Financial Statements of the Company for the year
ended 31st March 2026 and notes together with the Report of the Directors and the Auditors of the
Company and if thought fit, to pass, with or without modification(s).
To consider and if thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT the Audited Financial Statements of the Company for the Financial Year
ended 31st March 2026 along-with the reports of the Board of Directors and Auditors thereon, as
circulated to the members, be and are hereby considered and adopted.”
2. To declare the Final Dividend on Equity Shares for the Financial Year ended 31st March 2026 and,
in this regard,
To consider and if thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT approval be and is hereby accorded for declaration and payment of final
dividend of ₹ 0.50 (Rupees fifty paise only) per equity share of the face value of ₹ 10 (Rupee Ten)
each fully paid up, of the Company, as recommended by the Board of Directors for the financial
year ended 31st March 2026.
RESOLVED FURTHER THAT the said dividend be paid to those members whose names appear in
the register of members/ beneficial owners in the records of the depositories as on the record
date fixed for the purpose, through electronic modes or such other modes as may be permissible
under applicable law.”
3. Appointment of a director in the place of Ms. Sapna Parmar (DIN: 10198855), who retires by
rotation and being eligible, o ers herself for re-appointment
To consider, and if thought fit, to pass the following resolution as an Ordinary Resolution:
“RESOLVED THAT pursuant to the provisions of Section 152(6) and other applicable provisions of
the Companies Act, 2013, Ms. Sapna Parmar (DIN: 10198855), Director (Non-Executive) of the
Company, who retires by rotation at this annual general meeting and being eligible o ers herself
Notice of 9th AGM
for re-appointment, be and is hereby re-appointed as a Director (Non-Executive) of the
Company, liable to retire by rotation.”
SPECIAL BUSINESS
4. To approve the re-appointment of Mr. Tarun Gandhi (DIN: 07854699) as the Managing director of
the Company,
To consider and, if thought fit, pass the following resolution as Special Resolution:
“RESOLVED THAT pursuant to the provisions of Sections 196, 197, 198 and 203 read with Schedule V
and other applicable provisions of the Companies Act, 2013 (“Act”), the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014 and Regulation 17 of the
Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements)
Regulations, 2015 (“SEBI Listing Regulations”) (including any statutory modification(s),
amendments(s) or re-enactment thereof for the time being in force) and such other approvals,
permissions and sanctions, as may be required and pursuant to the provisions of the Articles of
Association of the Company and in line with the Remuneration Policy of the Company, and on
the recommendations of the Nomination & Remuneration Committee (“NRC”) and the Board of
Directors, consent of the members of the Company, be and is hereby accorded for the re-
appointment of Mr. Tarun Gandhi (DIN: 07854699) as Managing Director of the Company, not
liable to retire by rotation and a Key Managerial Personnel (KMP) of the Company, whose current
term of o ce is expiring on January 26, 2027, for a further period of 05 (five) years, with e ect from
January 27, 2027 till January 26, 2032, on the terms & conditions including remuneration as set
out hereunder, with the liberty to the Board of Directors [hereinafter referred to as the
“board”which term shall be deemed to NRC of the Board] to alter, vary and modify the terms &
conditions of the said appointment and/ or remuneration, in such manner, as may be agreed to
between the Board and Mr. Tarun Gandhi (DIN: 07854699) within and in accordance with the Act
or other applicable provisions or any amendment thereto:
Period of appointment: 05 (five) years, January 27, 2027 till January 26, 2032.
a) Basic Salary: Not exceeding ₹1,57,20,000/- (Rupees One Crore Fifty-Seven Lakh Twenty
Thousand only) per annum.
b) Perquisites and Allowances: NA
c) Reimbursement of Expenses: Reimbursement of expenses incurred for travelling, boarding, and
lodging during business trips; provision of cars for use on the Company’ business shall be
reimbursed and not considered as the Perquisites.
d) General:
(i) The Managing Director shall perform the duties as such with regard to all work of the Company
and he will manage and attend to such business and carry out the orders and directions given by
the Board, from time to time in all respect and confirm to and comply with all such directions and
regulations as may from time to time, be given and made by the Board.
(ii) The Managing Director shall act in accordance with the Articles of Association of the Company
and shall abide by the provisions contained in Section 166 of the Act with regard to the duties of
directors.
(iii) The Managin
[Showing first 8,000 characters — download PDF for full document]